ALB and metabolic dysfunction-associated steatotic liver disease: In this context, C‐reactive protein–albumin–lymphocyte (CALLY) index, an integrated biomarker reflecting inflammation, immune function, and nutritional status, may provide useful information for exploring early screening approaches and assessing the likelihood of NAFLD.